Broad portfolio of human-based controls
As tumor markers are produced by cancerous cells, tumor marker testing can be helpful in the screening, diagnosis, and treatment monitoring of cancer. We offer a broad portfolio of human-based tumor markers that include common analytes as well as specific, frequently used tumor marker analytes for breast and pancreatic cancers. Whether cancer center, core, or other specialty lab, our markers can be used alongside our leading Unity software for improved data management—ultimately helping increase reliability in patient test results.
With nearly 30 analytes, our portfolio includes markers for common analytes alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen 125 (CA 125), and prostate specific antigen (PSA), as well as frequently used analytes for breast and prostate cancers.
Our controls can be used on a variety of laboratory testing systems, including analyzers manufactured by Roche, Abbott, Siemens, Beckman, and Ortho, as well as other smaller instruments.
We offer controls as both Liquichek and Lyphochek products. Both InteliQ and Vista vial configurations are available for some of our Liquichek assays, and you can choose between liquid and lyophilized forms in regular vial configuration.
High-sensitivity controls help yield greater confidence in results
Multi-analyte controls help enable consolidated control materials
Multiple configurations help improve workflow efficiency
Long shelf lives save time and money
Compatibility with major analyzers helps improve testing capacity
Unity software offers large peer group for improved data management
Some benefits for registering